Wearable device for relieving neurotoxicity after chemotherapy

Abstract

The invention discloses a wearable device for relieving neurotoxicity after chemotherapy, and the device comprises a wearable assembly which is provided with a plurality of electrode patches, and the plurality of electrode patches are electrically connected through a flexible circuit; the control box is arranged on the outer side of the wearable assembly, and the flexible circuit is electrically connected with the control box; the control box comprises a connecting control seat, one side of the connecting control seat is fixedly connected with the wearable assembly, and a battery box is detachably arranged on the outer side of the connecting control seat. According to the wearable device for relieving neurotoxicity after chemotherapy, through the cooperative design of multiple structures, the device can conduct percutaneous acupoint electrical stimulation on the corresponding acupoints of the limbs of a patient, so that the effect of relieving neurotoxicity after chemotherapy is achieved, the working intensity of medical staff can be effectively reduced, and the working efficiency of the medical staff is improved. The limitation caused by auxiliary means due to personal experience is avoided, the operation requirement is low, long-term treatment of a patient at home is facilitated, the whole structure is simple, and use is convenient.

Description

Technical Field

[0001] The present invention relates to the technical field of medical supplies, and in particular to a wearable device for alleviating neurotoxicity after chemotherapy. Background Art

[0002] Chemotherapy-induced peripheral neuropathy (CIPN) is a neurotoxic lesion caused by direct damage to the peripheral nervous system by chemotherapy drugs. It is mainly manifested as symmetrical pain, numbness, and tactile abnormalities in the distal extremities. In severe cases, the proximal extremities may be involved, accompanied by loss of tendon reflexes or movement disorders. CIPN is mostly a dose-limiting toxic reaction. With the continuous accumulation of chemotherapy drug doses, the symptoms will also progressively worsen, and even cause permanent nerve damage. At present, Western medicine treatments including neurotrophic agents, antioxidants / cytoprotectants, and calcium-magnesium mixtures have been proven to have certain efficacy in preventing CIPN through clinical studies of different levels. With the continuous development of evidence-based medicine in traditional Chinese medicine, more and more clinical studies have reported that traditional Chinese medicine combined with neurotrophic agents, antioxidants, and calcium-magnesium mixtures can further reduce the incidence of CIPN, improve the quality of life, and enhance patients' tolerance and compliance to chemotherapy. There are many ways to administer Chinese medicine. External treatments such as acupuncture, moxibustion, and Chinese medicine fumigation directly act on the affected area. They are safe and fast, and have significant effects in preventing and treating CIPN.

[0003] However, there is currently no dedicated equipment for relieving neurotoxicity after chemotherapy. All of them are auxiliary means applied by medical staff based on their personal experience. The patient's hospitalization period is long, the technical requirements for medical staff are high, the repeatability is poor, and it is not convenient for patients to receive long-term home rehabilitation treatment. To this end, this application proposes a wearable device for relieving neurotoxicity after chemotherapy, which provides a new technical solution to solve the above-mentioned technical problems. Summary of the invention

[0004] Based on this, it is necessary to provide a wearable device for alleviating neurotoxicity after chemotherapy in response to the above-mentioned technical problems. Through the coordinated design of multiple structures, the device can perform transcutaneous electrical stimulation on the corresponding acupoints of the patient's limbs, thereby achieving the effect of alleviating neurotoxicity after chemotherapy. It can effectively reduce the workload of medical staff and avoid the limitations of auxiliary means due to personal experience. It has low operating requirements and is convenient for patients to receive long-term treatment at home. The overall structure is relatively simple and easy to use.

[0005] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0006] A wearable device for alleviating neurotoxicity after chemotherapy, which is used to relieve pain, numbness and tactile abnormalities in the distal extremities of tumor patients after chemotherapy.

[0007] The wearable device for alleviating neurotoxicity after chemotherapy specifically includes:

[0008] A wearable component, wherein the wearable component is provided with an electrode patch, wherein the number of the electrode patches is multiple, and the multiple electrode patches are electrically connected via a flexible circuit;

[0009] A control box, which is arranged on the outside of the wearable component, and the flexible circuit is electrically connected to the control box; the control box includes a connection control seat, one side of the connection control seat is fixedly connected to the wearable component, a battery box is detachably arranged on the outside of the connection control seat, the battery box is electrically connected to the connection control seat, and a protective box is sleeved on the outside of the battery box, and the protective box is buckled and connected to the connection control seat;

[0010] A binding component is arranged at a position outside the wearable component and is used for fixing the opening of the wearable component; the binding component includes a fixing belt and a Japanese-shaped buckle, the fixing belt is located at a position on one side of the wearable component, one end of the fixing belt is fixedly connected to the wearable component, the Japanese-shaped buckle is located at a position on the other side of the wearable component, the Japanese-shaped buckle is movably connected to the wearable component, and a Velcro is arranged on the outer side of the fixing belt away from one end of the wearable component, and the fixing belt is adhered and fixed to itself by the Velcro.

[0011] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, the wearable component includes a hand wear piece and a foot wear piece, the electrode patches on the hand wear piece correspond to the positions of the Baxie, Laogong, Waiguan, and Hegu acupoints, respectively, and the electrode patches on the foot wear piece correspond to the positions of the Bafeng, Yongquan, and Sanyinjiao acupoints, respectively.

[0012] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, the connection control seat includes a mounting seat, a control circuit board is arranged inside the mounting seat, a pin socket is arranged at one end of the control circuit board, the pin socket extends to the inner side of the mounting seat, both ends of the inner side of the mounting seat are vertically fixedly connected with positioning columns, the positioning column extends to the outer side of the mounting seat away from one end of the mounting seat, and limiting convex strips are arranged on both sides of the inner wall of the mounting seat.

[0013] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, the battery box includes a battery body, both ends of the battery body are provided with a positioning groove one, the positioning groove one is plug-connected with the positioning column, the battery body is plug-connected with the mounting seat, both sides of the battery body are provided with limiting grooves, the battery body is buckled and connected with the limiting convex strip through the limiting groove, and the side of the battery body close to the mounting seat is provided with a pin plug that matches the pin socket.

[0014] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, the protective box includes a protective shell, and the protective shell has two positioning grooves at both ends. The protective shell is plug-connected with the positioning column through the two positioning grooves, and buckle components are provided on both sides of the protective shell, and the protective shell is buckled and connected with the connecting control seat through the buckle components.

[0015] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, an anti-sway gasket is provided on the inner side of the protective box, a connecting groove is provided on the side of the protective shell away from the connection control seat, a connecting protrusion is fixedly connected to one side of the anti-sway gasket, the anti-sway gasket is plug-connected to the connecting groove through the connecting protrusion, and a reserved groove is provided on the other side of the anti-sway gasket.

[0016] As a preferred embodiment of the wearable device for alleviating post-chemotherapy neurotoxicity provided by the present invention, the buckle assembly includes a splint, two splints are symmetrically arranged on the outer side of the protective shell, and the two splints are rotatably connected to the protective shell, and a reed is arranged at one end of the two splints away from the connection control seat, and the reed is located at a position between the ends of the two splints, and the two ends of the reed are respectively plugged and connected to the two splints, and the ends of the two splints close to the connection control seat are fixedly connected with a buckle frame, and limiting buckle grooves are opened on the outer side of the mounting seat and at positions corresponding to the two splints, and the splints are buckled and connected with the limiting buckle grooves opened on the outer side of the mounting seat through the buckle frame.

[0017] As a preferred embodiment of the wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention, a binding groove is provided on a side of the protective shell away from the connection control seat.

[0018] Compared with the prior art, the present invention has the following beneficial effects:

[0019] The wearable device for relieving neurotoxicity after chemotherapy provided by the present invention, through the coordinated design of multiple structures, enables the device to achieve the effect of relieving neurotoxicity after chemotherapy by performing transcutaneous electrical acupoint stimulation on the corresponding acupoints of the patient's limbs, which can effectively reduce the workload of medical personnel and avoid the limitations brought about by auxiliary means due to personal experience. The operation requirements are relatively low, and it is convenient for patients to receive long-term treatment at home. The overall structure is relatively simple and easy to use.

[0020] The wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention has a detachable structural design of the control box, so that the battery box and the protective box in the control box can be removed or replaced separately, thereby avoiding the risk of the battery box accidentally falling off or the battery box being damaged by collision. When the battery box is exhausted, the battery box can be directly removed and replaced for continued use. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the scheme of the present invention, a brief introduction is given below to the drawings required for use in the description of the embodiments. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0022] Figure 1 A schematic diagram of the overall structure of a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0023] Figure 2 A rear view of the overall structure of the wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0024] Figure 3 A schematic diagram of the structure of a control box of a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0025] Figure 4 A schematic diagram of the structure of a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention connected to a control seat;

[0026] Figure 5 A schematic diagram of the structure of a battery box for a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0027] Figure 6 A rear view of the structure of a battery box for a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0028] Figure 7 A schematic diagram of the structure of a protective box and a buckle assembly of a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0029] Figure 8 A schematic diagram of the structure of an anti-sway gasket for a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention;

[0030] Fig. 9 A rear view of the structure of an anti-sway gasket for a wearable device for alleviating neurotoxicity after chemotherapy provided by the present invention.

[0031] The markings in the figure are as follows:

[0032] 1. Wearable component; 2. Electrode patch; 3. Flexible circuit; 4. Control box; 5. Fixing belt; 6. Japanese buckle; 7. Velcro; 8. Connecting control seat; 9. Battery box; 10. Protective box; 11. Snap-fit ​​component; 12. Mounting seat; 13. Limit buckle groove; 14. Pin socket; 15. Positioning column; 16. Limiting convex strip; 17. Battery body; 18. Positioning groove 1; 19. Limiting groove; 20. Pin plug; 21. Protective shell; 22. Anti-sway gasket; 23. Connecting groove; 24. Connecting convex block; 25. Positioning groove 2; 26. Reserved groove; 27. Clamp; 28. Spring leaf; 29. ​​Buckle frame; 30. Binding groove. DETAILED DESCRIPTION

[0033] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0034] As described in the background technology, there is currently no dedicated equipment in clinical practice for relieving neurotoxicity after chemotherapy. All of them are auxiliary means applied by patients or medical staff based on their personal experience, which often have poor relief effects, high operating requirements, poor repeatability, and are not convenient for patients to undergo long-term home rehabilitation treatment.

[0035] In order to solve this technical problem, the present invention provides a wearable device for alleviating neurotoxicity after chemotherapy, which is used to alleviate pain, numbness, and tactile abnormalities in the distal limbs of cancer patients after chemotherapy.

[0036] Specifically, please refer to Figure 1 - Figure 3 , wearable devices that alleviate neurotoxicity after chemotherapy include:

[0037] A wearable component 1, on which an electrode patch 2 is disposed, the number of the electrode patch 2 is multiple, and the multiple electrode patches 2 are electrically connected via a flexible circuit 3;

[0038] A control box 4 is arranged outside the wearable component 1, and the flexible circuit 3 is electrically connected to the control box 4; the control box 4 includes a connection control seat 8, one side of the connection control seat 8 is fixedly connected to the wearable component 1, and a battery box 9 is detachably arranged outside the connection control seat 8, and the battery box 9 is electrically connected to the connection control seat 8. A protective box 10 is sleeved outside the battery box 9, and the protective box 10 is buckled and connected to the connection control seat 8;

[0039] A binding component is arranged at a position outside the wearing component 1 and is used for fixing the opening of the wearing component 1; the binding component includes a fixing belt 5 and a Japanese-shaped buckle 6, the fixing belt 5 is located at a position on one side of the wearing component 1, one end of the fixing belt 5 is fixedly connected to the wearing component 1, the Japanese-shaped buckle 6 is located at a position on the other side of the wearing component 1, the Japanese-shaped buckle 6 is movably connected to the wearing component 1, and a Velcro 7 is arranged on the outer side of the fixing belt 5 away from one end of the wearing component 1, and the fixing belt 5 is adhered and fixed to itself by the Velcro 7.

[0040] The wearable device for relieving neurotoxicity after chemotherapy provided by the present invention, through the coordinated design of multiple structures, enables the device to achieve the effect of relieving neurotoxicity after chemotherapy by performing transcutaneous electrical acupoint stimulation on the corresponding acupoints of the patient's limbs, which can effectively reduce the workload of medical personnel and avoid the limitations brought about by auxiliary means due to personal experience. The operation requirements are relatively low, and it is convenient for patients to receive long-term treatment at home. The overall structure is relatively simple and easy to use.

[0041] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings.

[0042] Embodiment 1:

[0043] Please refer to Figure 1 - Figure 2 , a wearable device for alleviating neurotoxicity after chemotherapy, comprising:

[0044] A wearable component 1, on which an electrode patch 2 is disposed, the number of the electrode patch 2 is multiple, and the multiple electrode patches 2 are electrically connected via a flexible circuit 3;

[0045] A control box 4 is arranged outside the wearable component 1, and the flexible circuit 3 is electrically connected to the control box 4; specifically, the control box 4 includes a connection control seat 8, one side of the connection control seat 8 is fixedly connected to the wearable component 1, and a battery box 9 is detachably arranged outside the connection control seat 8, and the battery box 9 is electrically connected to the connection control seat 8. A protective box 10 is sleeved outside the battery box 9, and the protective box 10 is buckled and connected to the connection control seat 8;

[0046] Furthermore, the wearable component 1 includes a hand wearable component and a foot wearable component. The electrode patches 2 on the hand wearable component correspond to the positions of the Baxie, Laogong, Waiguan, and Hegu acupoints respectively, and the electrode patches 2 on the foot wearable component correspond to the positions of the Bafeng, Yongquan, and Sanyinjiao acupoints respectively.

[0047] It can be seen that the patient wears the component 1 on the hand or foot, and connects multiple electrode patches 2 with the control box 4 through the soft circuit 3, so that the electrode patch 2 can be controlled by the control box 4 to perform transcutaneous acupoint electrical stimulation on the patient's limbs, such as the Baxie, Laogong, Waiguan, Hegu, Bafeng, Yongquan, Sanyinjiao and other acupoints, thereby achieving the effect of relieving discomfort after chemotherapy.

[0048] A binding component is arranged at a position outside the wearing component 1 and is used for fixing the opening of the wearing component 1; specifically, the binding component includes a fixing belt 5 and a Japanese-shaped buckle 6, the fixing belt 5 is located at a position on one side of the wearing component 1, one end of the fixing belt 5 is fixedly connected to the wearing component 1, the Japanese-shaped buckle 6 is located at a position on the other side of the wearing component 1, the Japanese-shaped buckle 6 is movably connected to the wearing component 1, and a Velcro 7 is arranged on the outer side of the fixing belt 5 away from one end of the wearing component 1, and the fixing belt 5 is adhered and fixed to itself by the Velcro 7.

[0049] It can be seen that after the patient wears the component 1 on the hand or foot, the fixing belt 5 is wrapped around one side of the wearing component 1 and passed through the inner side of the Japanese buckle 6. Then, the tightening effect at the opening of the wearing component 1 can be achieved by dragging the fixing belt 5, and the fixing belt 5 is fixed by the Velcro 7 arranged on the outside of the fixing belt 5, thereby ensuring the firmness of the wearing of the wearing component 1.

[0050] Among them, the wearable component 1 has models of multiple different sizes, which is convenient for wearing the appropriate size according to the body shape.

[0051] Embodiment 2:

[0052] The wearable device for alleviating neurotoxicity after chemotherapy provided in Example 1 is further optimized, specifically, Figure 3-Figure 8 As shown, the connection control seat 8 includes a mounting seat 12, a control circuit board is arranged inside the mounting seat 12, a pin socket 14 is arranged at one end of the control circuit board, the pin socket 14 extends to the inner side of the mounting seat 12, both ends of the inner side of the mounting seat 12 are vertically fixedly connected with positioning columns 15, the positioning columns 15 extend to the outer side of the mounting seat 12 away from one end of the mounting seat 12, and limiting convex strips 16 are arranged on both sides of the inner wall of the mounting seat 12.

[0053] Specifically, the battery box 9 includes a battery body 17, both ends of the battery body 17 are provided with positioning grooves 18, the positioning grooves 18 are plugged into the positioning column 15, the battery body 17 is plugged into the mounting seat 12, both sides of the battery body 17 are provided with limiting grooves 19, the battery body 17 is snap-fitted with the limiting convex strips 16 through the limiting grooves 19, and a pin plug 20 that matches the pin socket 14 is provided on one side of the battery body 17 close to the mounting seat 12.

[0054] Specifically, the protective box 10 includes a protective shell 21, a protective shell 21, and positioning grooves 25 are provided at both ends of the protective shell 21. The protective shell 21 is plugged into the positioning column 15 through the positioning grooves 25. Both sides of the protective shell 21 are provided with snap-fit ​​components 11, and the protective shell 21 is snap-fitted with the connecting control seat 8 through the snap-fit ​​components 11.

[0055] Through the above-mentioned structural design, the start-up control of the electrode patch 2 can be realized by the control circuit board arranged on the inner side of the connection control seat 8. After the battery box 9 is plugged into the connection control seat 8, the electrical connection between the connection control seat 8 and the battery box 9 can be realized through the cooperation of the pin socket 14 and the pin plug 20, so that the power supply of the device can be realized through the battery box 9, and the protection of the battery box 9 can be realized by the protective box 10 being sleeved on the outer side of the battery box 9; wherein, during the plugging process of the battery box 9 and the connection control seat 8, the insertion of the battery box 9 can be guided by the cooperation of the positioning column 15 and the positioning groove 18, and the battery box 9 can be limited after insertion by the cooperation of the limiting convex strip 16 and the limiting groove 19, so as to avoid the battery box 9 from accidentally slipping off; during the installation process of the protective box 10, the installation and positioning of the protective box 10 can be realized by the cooperation of the positioning column 15 and the positioning groove 25, and after the protective box 10 is installed, the buckling connection with the connection control seat 8 can be realized through the buckling component 11, so as to achieve the fixing effect of the protective box 10 after installation.

[0056] Embodiment 3:

[0057] The wearable device for alleviating neurotoxicity after chemotherapy provided in Example 2 is further optimized. Specifically, Figure 8-Figure 9 As shown, an anti-sway gasket 22 is provided on the inner side of the protective box 10, a connecting groove 23 is provided on the side of the protective shell 21 away from the connection control seat 8, a connecting protrusion 24 is fixedly connected to one side of the anti-sway gasket 22, the anti-sway gasket 22 is plugged into the connecting groove 23 via the connecting protrusion 24, and a reserved groove 26 is provided on the other side of the anti-sway gasket 22.

[0058] Through the above-mentioned structural design, after the protective box 10 is installed and fixed, the anti-sway gasket 22 fits the battery box 9, so that the connection effect between the battery box 9 and the connection control seat 8 can be further improved, and the connection between the anti-sway gasket 22 and the protective box 10 is realized by plugging the connecting protrusion 24 into the connecting groove 23. Therefore, when the protective box 10 is taken and placed, the anti-sway gasket 22 is always located inside the protective box 10, and the reserved groove 26 opened on the outside of the anti-sway gasket 22 allows the anti-sway gasket 22 to deform during the squeezing process of the battery box 9.

[0059] Embodiment 4:

[0060] The wearable device for alleviating neurotoxicity after chemotherapy provided in Example 2 is further optimized. Specifically, Figure 7-Figure 8 As shown, the snap-fit ​​assembly 11 includes a clamp 27, and two clamps 27 are symmetrically arranged on the outer side of the protective shell 21, and the two clamps 27 are rotatably connected to the protective shell 21. A spring 28 is arranged at one end of the two clamps 27 away from the connection control seat 8, and the spring 28 is located between the ends of the two clamps 27. The two ends of the spring 28 are respectively plug-connected with the two clamps 27, and the ends of the two clamps 27 close to the connection control seat 8 are fixedly connected with a buckle frame 29. A limiting buckle groove 13 is opened on the outer side of the mounting seat 12 and at the position corresponding to the two clamps 27, and the clamp 27 is buckled and connected with the limiting buckle groove 13 opened on the outer side of the mounting seat 12 through the buckle frame 29.

[0061] Through the above-mentioned structural design, during the installation process of the protective box 10, the two clamps 27 are pressed by two fingers to make the two clamps 27 move closer to each other at one end away from the connection control seat 8, thereby squeezing the spring 28, causing the spring 28 to deform and accumulate force. After the protective box 10 is sleeved on the outside of the battery box 9 and the edge of the protective box 10 is in contact with the connection control seat 8, the clamps 27 are released, and at the same time, the spring 28 releases the stored force, pushing the clamps 27 to reset, so that the reset clamps 27 are snapped with the limiting snap groove 13 through the snap frame 29, thereby completing the snap connection between the protective box 10 and the connection control seat 8.

[0062] Embodiment 5:

[0063] The wearable device for alleviating neurotoxicity after chemotherapy provided in Example 2 is further optimized. Specifically, Figure 7-Figure 8 As shown, a binding groove 30 is formed on a side of the protective shell 21 away from the connection control seat 8 .

[0064] Through the above-mentioned structural design, after the protective box 10 is installed, the wearable component 1 is fixed by the binding component, wherein the fixing belt 5 can extend into the binding groove 30, so as to achieve the effect of binding the control box 4 after the fixing belt 5 is fixed, thereby further ensuring the connection stability of the control seat 8, the battery box 9, and the protective box 10.

Claims

1. A wearable device for alleviating neurotoxicity after chemotherapy, characterized in that: include: A wearable component (1), wherein an electrode patch (2) is arranged on the wearable component (1), the electrode patch (2) is in a plurality, and the plurality of electrode patches (2) are electrically connected via a flexible circuit (3); A control box (4) is arranged on the outside of the wearable component (1), and the flexible circuit (3) is electrically connected to the control box (4); the control box (4) comprises a connection control seat (8), one side of the connection control seat (8) is fixedly connected to the wearable component (1), a battery box (9) is detachably arranged on the outside of the connection control seat (8), the battery box (9) is electrically connected to the connection control seat (8), a protective box (10) is sleeved on the outside of the battery box (9), and the protective box (10) is snap-fitted and connected to the connection control seat (8); A binding component is arranged at a position outside the wearable component (1) and is used for fixing the opening of the wearable component (1); the binding component comprises a fixing belt (5) and a Japanese-shaped buckle (6); the fixing belt (5) is located at a position on one side of the wearable component (1); one end of the fixing belt (5) is fixedly connected to the wearable component (1); the Japanese-shaped buckle (6) is located at a position on the other side of the wearable component (1); the Japanese-shaped buckle (6) is movably connected to the wearable component (1); a Velcro (7) is arranged on the outer side of one end of the fixing belt (5) away from the wearable component (1); the fixing belt (5) is adhered and fixed to itself via the Velcro (7).

2. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 1, characterized in that: The wearable component (1) comprises a hand wearable component and a foot wearable component, wherein the electrode patches (2) on the hand wearable component correspond to the positions of the eight evil points, Laogong, Waiguan, and Hegu acupoints respectively, and the electrode patches (2) on the foot wearable component correspond to the positions of the eight wind points, Yongquan, and Sanyinjiao acupoints respectively.

3. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 1, characterized in that: The connection control seat (8) comprises a mounting seat (12), a control circuit board is arranged inside the mounting seat (12), a pin socket (14) is arranged at one end of the control circuit board, the pin socket (14) extends to the inside of the mounting seat (12), both ends of the inside of the mounting seat (12) are vertically fixedly connected with positioning columns (15), one end of the positioning column (15) away from the mounting seat (12) extends to the outside of the mounting seat (12), and both sides of the inner wall of the mounting seat (12) are provided with limiting convex strips (16).

4. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 3, characterized in that: The battery box (9) comprises a battery body (17), both ends of the battery body (17) are provided with a positioning groove (18), the positioning groove (18) is plug-connected with the positioning column (15), the battery body (17) is plug-connected with the mounting seat (12), both sides of the battery body (17) are provided with a limiting groove (19), the battery body (17) is buckled and connected with the limiting convex strip (16) through the limiting groove (19), and a pin plug (20) matching with the pin socket (14) is provided on one side of the battery body (17) close to the mounting seat (12).

5. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 3, characterized in that: The protective box (10) comprises a protective shell (21), wherein both ends of the protective shell (21) are provided with positioning grooves (25), and the protective shell (21) is plug-connected with the positioning column (15) through the positioning grooves (25). Both sides of the protective shell (21) are provided with snap-fit ​​components (11), and the protective shell (21) is snap-fitted with the connection control seat (8) through the snap-fit ​​components (11).

6. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 5, characterized in that: An anti-sway gasket (22) is arranged on the inner side of the protection box (10); a connecting groove (23) is provided on the side of the protection shell (21) away from the connection control seat (8); a connecting protrusion (24) is fixedly connected to one side of the anti-sway gasket (22); the anti-sway gasket (22) is plug-connected to the connecting groove (23) via the connecting protrusion (24); and a reserved groove (26) is provided on the other side of the anti-sway gasket (22).

7. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 5, characterized in that: The buckle assembly (11) comprises a clamping plate (27), two clamping plates (27) are symmetrically arranged on the outer side of the protective shell (21), and the two clamping plates (27) are rotatably connected to the protective shell (21), and a spring (28) is arranged at one end of the two clamping plates (27) away from the connection control seat (8), and the spring (28) is located between the ends of the two clamping plates (27), and the two ends of the spring (28) are respectively plug-connected with the two clamping plates (27), and the ends of the two clamping plates (27) close to the connection control seat (8) are fixedly connected with a buckle frame (29), and a limiting buckle groove (13) is provided on the outer side of the mounting seat (12) and at a position corresponding to the two clamping plates (27), and the clamping plate (27) is buckled and connected with the limiting buckle groove (13) opened on the outer side of the mounting seat (12) through the buckle frame (29).

8. The wearable device for alleviating neurotoxicity after chemotherapy according to claim 5, characterized in that: A binding groove (30) is provided on a side of the protective shell (21) away from the connection control seat (8).

Images